Tempus is a health-tech platform that combines genomic, clinical, imaging, and real‑world data into one place using AI, for convenience.
Introduction
Tempus makes good on its mission, “It’s About Time”, by using AI to customize care journeys in oncology, cardiology, radiology, neurology, psychiatry, and depression. It changed its name from Tempus Labs to Tempus AI to demonstrate its increasing devotion to AI. Public since June 14, 2024 (NASDAQ: TEM). With more than 2,300 staff and a CAP/CLIA lab infrastructure in the U.S. and Spain, it seeks to integrate diagnostics, patient information, and generative AI into an integrated health‑tech platform.
Enterprise
AI‑Driven
Multimodal Data
GenAI Assistants
Review
Tempus is a health-tech platform that combines genomic, clinical, imaging, and real‑world data into one place using AI. It provides clinicians, researchers, and pharma firms with tools for precision medicine. Its modular structure, spanning diagnostics, data analytics, cohort formation, trial matching, and care pathway alerts, is one of the most mature in the market. Enterprise‑level deployment is a complexity cost, but for large systems it provides actionable insights at scale.
Features
Genomic & Imaging Diagnostics
NGS sequencing, cardiology and digital‑pathology assays, FDA‑cleared ECG-AF and "al‑gos" diagnostics.
Tempus One
AI clinical assistant for providers, with generative‑AI voice/text query, trial matching, cohort building, evidence retrieval, and order management.
Lens & Cohort Builder
Allows researchers to interrogate multimodal structured and unstructured data with natural language, based on generative‑AI agents.
Loop
Beta oncology target discovery platform that combines real‑world data and CRISPR and organoid models to speed up drug development.
Next
Care pathway intelligence notifies providers about guideline variances in real time through EMR integration (utilized in cardiology and oncology).
Olivia
AI-based mobile health app for patients to consolidate EHR and device data, timeline visualization, and pose questions for summaries; launched beta Jan 2025.
Best Suited for
Healthcare Systems & Hospitals
To provide AI-enabled diagnostics and care-pathway notification at scale (50% of U.S. oncologists connected).
Pharma/Biotech
To create cohorts, pair trials, and identify targets with Loop and de-identified data assets.
Clinicians in Oncology/Cardiology
Utilizing Tempus One and Next to navigate complicated care plans and genomic understanding.
Researchers & Data Scientists
Using Lens and Cohort Builder for real-world evidence and unstructured data mining.
Patients & Caregivers
Through Olivia to summarize health data and get AI-driven summaries.
Strengths
Authentic multimodal data integration, genomics, labs, imaging, real-world data.
FDA-cleared AI tools such as ECG-AF and histogenomics; strong GenAI for cohort and trial matching.
Platform agility, supporting clinicians, enterprises, research, pharma, and patients within a single OS.
Enormous proprietary data (~250 petabytes, 250k+ patients) fueling model enhancement.
Weakness
Enterprise‑sized, complex configuration restricts access by smaller clinics or individuals.
Pricing is opaque and customized, with restricted free or SMB access.
Getting started with: step by step guide
Getting started with Tempus is straight forward:
Step 1: Contact Sales
Go to their website and ask for a demo or implementation call. Enterprise agreements necessary.
Step 2: Onboard Data Sources
Attach lab pipelines, EMR/EHR, imaging systems, or existing databases to Tempus modules.
Step 3: Start with a Module
Select your priority, diagnostic pipelines, care pathway notifications, research cohort access, or patient app.
Step 4: Train & Validate Locally
Utilize FDA‑cleared models and set up thresholds, alerts, and workflows while maintaining compliance.
Step 5: Scale Across Departments
Deploy to specialties, cancer centers, cardiology units, research teams, etc. Track usage and results.
Frequently Asked Questions
Q: What is Tempus?
A: An artificial-intelligence platform combining diagnostics, multimodal data, and generative-AI with tools for clinicians, researchers, and patients.
Q: Is there a free version?
A: No consumer tier exists; pricing is enterprise‑level and customized.
Q: How is data privacy handled?
A: HIPAA‑compliant infrastructure, de‑identification for research exports, and FDA‑regulated medical devices in place.
Pricing
Not publicly disclosed (enterprise/custom pricing).
Alternatives
Guardant Health
Liquid biopsy pioneer.
Google Health/DeepMind
Research-grades AI within healthcare verticals.
PathAI
AI platform for digital pathology.
Share it on social media:
Questions and answers of the customers
There are no questions yet. Be the first to ask a question about this product.

Leave feedback about this